Ann: Sensera Working Capital Financing to Support Revenue Growth, page-12

As far as I understand, our sensor is in the latest version of the Impella, namely Impella CP with Smart Assist - FDA approval for this was only granted in April 2018. See below article.

https://www.dicardiology.com/product/fda-approves-abiomed-impella-cp-smartassist-and-optical-sensor

It’s their first pump which utilises a optical sensor - this is where Sensera comes in. The article goes through this in more detail - goes into location awareness, real-time data analytics etc.

So ISO rating came just in time for them to produce commercially. So if you ask me, we have barely tasted revenue from Abiomed thus far. Of course this is about to change real quick as commercialisation ramps up. I can see our revenues increasing dramatically very shortly.